Finance

Precigen to Reveal Precision Medicine Insights

By Daybreak Brief Editorial Team

Precigen, a biopharma company, is gearing up for some big chats with investors. They'll be rubbing elbows at the J.P. Morgan virtual fireside on June 1 and the Goldman Sachs conference from June 8 to 10. CEO Helen Sabzevari and other top execs will be spilling the beans on their cutting-edge work in precision medicine. What does it mean for you? If you're into healthcare stocks or just curious about the future of medicine, these chats could give you the inside scoop on what's next in the fight against tough diseases.

Original source Read the full story →
▲ 1,284 voters this week
How we select stories →
More from this briefing
China and Serbia Expand Strategic Partnership → Award-Winning AirX Case: Style Meets Sustainability → Dinto Solar Unveils High-Efficiency Panels at Intersolar → Data Centers Boost Reliability with Generator Growth → Greenberg Traurig Boosts Energy Practice with Yoshida → Lyon and Grenoble's Bold Green Transformation Journey → AirX Case Wins Top Design Awards 2026 → AirX Phone Case Wins Prestigious Design Awards → Borr Drilling Aims for Early Debt Buyback → Borr Drilling Plots $1.6B Debt Refinancing Adventure → DIRECTV's $1.4B Note Buyback Exceeds Expectations → US-China Summit: Complex Relations, No Trade Deals → Beijing's Diplomatic Spotlight: More Show Than Substance → PrismML Unveils Fast, Private On-Device Image Models → AI Challenges Cloud Security: Companies Struggle to Adapt → VersaBank to Unveil Q2 2026 Financial Results → VEVOR Launches Power 15 Deal Days in Houston → Uniting for Peace in the Chaotic Sahel → Class Struggles Persist in UK TV Industry →

Get stories like this every morning.

Five-minute intelligence briefing — in your inbox at 6 AM.

Subscribe now →